Robert Carradine, bipolar disorder
Digest more
Kerry Washington, who has struggled with an eating disorder for much of her adult life, opens up about her lifelong
MedPage Today on MSN
New Pill Approved for Schizophrenia, Bipolar Disorder
Milsaperidone is an active metabolite of iloperidone
The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.
Eating disorders are some of the most deadly psychiatric illnesses in the country, with the second-highest mortality rate after opioid addiction.
Scrupulosity is a form of obsessive-compulsive disorder (OCD) characterized by persistent and excessive concerns about moral or religious correctness.
Milsaperidone, a new chemical entity, is the major active metabolite of iloperidone (Fanapt) and had been demonstrated to be bioequivalent to iloperidone.
Researchers say the study provides insight into how early biological stress shapes addictive behaviors and identifies a potential approach for lowering risks.
Clients may present with anxiety or trauma while eating disorder symptoms remain hidden.